Deferred Tax Assets, Gross in USD of Burning Rock Biotech Ltd from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Burning Rock Biotech Ltd quarterly Deferred Tax Assets, Gross history and change rate from Q4 2020 to Q4 2024.
  • Burning Rock Biotech Ltd Deferred Tax Assets, Gross for the quarter ending 31 Dec 2024 was $83,468,000, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

Burning Rock Biotech Ltd Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $83,468,000 +$7,672,000 +10% 31 Dec 2024 20-F 29 Apr 2025 2024 FY
Q4 2023 $75,796,000 +$10,483,000 +16% 31 Dec 2023 20-F 29 Apr 2024 2023 FY
Q4 2022 $65,313,000 +$19,329,000 +42% 31 Dec 2022 20-F 20 Apr 2023 2022 FY
Q4 2021 $45,984,000 +$19,885,000 +76% 31 Dec 2021 20-F 29 Apr 2022 2021 FY
Q4 2020 $26,099,000 31 Dec 2020 20-F 23 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.